These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Rational substitution using stored blood and blood components]. Bünte S; Ludwig WD Dtsch Med Wochenschr; 1994 Nov; 119(45):1555-60. PubMed ID: 7956791 [No Abstract] [Full Text] [Related]
5. [Good use of blood transfusions: principal indications for hemotherapy]. Goudemand M; Bauters F; Parquet-Gernez A Lille Med; 1974; 19 Spec No():377-85. PubMed ID: 4437301 [No Abstract] [Full Text] [Related]
6. The Ottawa Statement. International registration of protocol information and results from human trials of health related interventions. Fedorowicz Z; Al-Hajeri AA Saudi Med J; 2005 Dec; 26(12):1860-1. PubMed ID: 16380762 [No Abstract] [Full Text] [Related]
7. What do people at risk for Alzheimer disease think about surrogate consent for research? Schenk DB; Gilman S Neurology; 2006 Jun; 66(11):1785-6. PubMed ID: 16769971 [No Abstract] [Full Text] [Related]
9. International ethical guidelines for biomedical research involving human subjects. Council for International Organizations of Medical Sciences Bull Med Ethics; 2002 Oct; (182):17-23. PubMed ID: 14983848 [TBL] [Abstract][Full Text] [Related]
10. A critical need to reconsider cancer trial eligibility requirements. Markman M Oncology; 2010; 79(1-2):1-2. PubMed ID: 21051911 [No Abstract] [Full Text] [Related]
11. Lower phenytoin serum levels in persons switched from brand to generic phenytoin. Stetz SA Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118861 [No Abstract] [Full Text] [Related]
12. [Resuspension of erythrocyte concentrates: clinical examinations with human albumin and oxypolygelatine]. Unseld H; Schlürmann D; Pfaender M; Voigt E Infusionsther Klin Ernahr; 1981 Jun; 8(3):141-5. PubMed ID: 6790436 [TBL] [Abstract][Full Text] [Related]
13. [The possibility of blood component therapy in Croatia (author's transl)]. Grgicević D; Bozović I; Pende B Lijec Vjesn; 1981; 103(2-3):119-22. PubMed ID: 7311696 [No Abstract] [Full Text] [Related]
14. [Replacing the administration of whole blood with blood derivatives]. Baklaja R Bilt Hematol Transfuz; 1982; 10(2-3):115-29. PubMed ID: 6927292 [No Abstract] [Full Text] [Related]
16. Selecting promising ALS therapies in clinical trials. Glass JD; Benatar M; Polak M Neurology; 2007 May; 68(18):1545-6; author reply 1546. PubMed ID: 17470765 [No Abstract] [Full Text] [Related]
17. Optimal use of blood components and derivatives. Walter WJ; Oberman HA Otolaryngol Clin North Am; 1981 Aug; 14(3):739-53. PubMed ID: 6795570 [No Abstract] [Full Text] [Related]
18. Blood products. Med Lett Drugs Ther; 1979 Nov; 21(23):93-6. PubMed ID: 502967 [No Abstract] [Full Text] [Related]